CROI 2020 Abstract eBook

Abstract eBook

General Information

ABSTRACT PROCESS

Special Notes on Abstract Content Presentations from randomized trials and cohorts should follow the International Committee of Medical Journal Editors (ICMJE) guidelines, including reporting of study designs, (eg, prospective, observational, randomized, double-blind, STROBE, CONSORT, or others), statistical methods, and outcomes by demographic variables. Appropriate information and correct terminology should be used with regard to sex and gender . For human clinical or epidemiologic studies, sex-stratified results should be provided or who was included if the study includes only a single population. Appropriate terminology such as cisgender (people whose gender match the sex assigned at birth) or transgender (people whose gender does not match the sex assigned at birth) should be used. Both sex and gender data should be provided in the presentation. Presentations of preclinical data including use of cell lines and animal studies should include the sex of the animals or the sex of the source of the cell lines. If data are not available on sex and gender, this should be identified as a limitation in your presentation. Out of respect for their contributions to our scientific advances, avoid calling study volunteers“subjects.” The preferred terms are study “participants”or“volunteers.” Presenting Author Responsibilities The presenting author is responsible for presenting the abstract at the conference and must be present at the poster during the entire session. Submitting authors are responsible for ensuring that all coauthors have reviewed and approved the abstract contents before submission. Embargo Policies and Social Media All research presented at CROI 2020 is embargoed until the conclusion of the study’s presentation at the conference. For example, if a study is presented from 2:15 PM to 2:30 PM, as part of a session that begins at 2:00 PM and ends at 3:00 PM, the embargo on that study lifts at 2:30 PM. Embargoes on poster presentations lift at the beginning of the session in which the poster is presented. If a study to be presented at CROI 2020 is included in an official CROI press conference that takes place before the scheduled presentation of the study, the embargo on that study lifts at the conclusion of the press conference panel in which the study is featured.

Scientific Categories A. Virology B. Pathogenesis: Human Studies and Animal Models C. HIV-Associated Tumor Viruses D. Host Immune Responses to Infection, Vaccines, and Immunotherapy E. HIV Reservoirs, Latency, and All Curative Strategies Including Therapeutic Vaccines and Gene Therapy F. Neuropathogenesis and Neurologic Complications G. Clinical Pharmacology H. Antiretroviral Therapy: Pre-Clinical Data, Randomized Trials, Efficacy and Effectiveness Studies I. HIV Drug Resistance J. Hepatitis Viruses and Liver Complications K. AIDS-Related Malignancies L. Cardiovascular Complications of HIV Infection and Antiretroviral Therapy M. Other Complications of HIV Infection and Antiretroviral Therapy N. Tuberculosis and Other Opportunistic Infections O. Maternal and Fetal HIV P. Pediatrics and Adolescents Q. Epidemiology R. Testing S. Prevention Interventions T. Contraception, Sexually Transmitted Infections, and Reproductive Health U. Implementation and Scale-Up of Treatment and Care Abstract Content Author names, institutions, titles, and abstracts in the CROI Program and Information Guide, Abstract eBook, Mobile App, and other materials are presented largely as submitted by the submitting author. The submitting author is responsible for ensuring that all coauthors have reviewed and approved the abstract before submission and for providing the complete and accurate contact information for all authors, including email address. THE SUBMITTING AUTHOR MUST ENSURE THAT THE EMAIL ADDRESSES OF ALL LISTED AUTHORS IN THEIR SUBMISSION ARE CORRECT in order for authors to receive important information regarding dispositions, presentation details, registration and housing information, and other CROI-related announcements.

General Information

2

CROI 2020